Ge Z H, Li H, Liu C G, Ruan J X
Institute of Pharmacology and Toxicology, Academy of Military Medical Sciences, Beijing 100850.
Yao Xue Xue Bao. 1997 Sep;32(9):652-7.
The metabolism of tricyclopinate hydrochloride(TCPN), a new anticholinergic agent, was studied by in situ perfused rat liver preparation. Two metabolites were isolated by HPLC. Metabolite I was identified as an N-demethylation product, while metabolite II was shown to be an arylhydroxylation product. Metabolite I and metabolite II were also isolated from the urine of the rat given TCPN i.g. This result shows that the two metabolites from the perfused rat liver are just the final metabolites produced in vivo. The metabolites in rat liver microsomes were also identified as those just described. These results suggest that the biotransformation reaction of TCPN is mainly catalyzed by the enzyme in rat liver microsomes. The results of experiment on receptor activity indicate that the action potency with mAChR of metabolite I and metabolite II was only 1/20 and 1/50, respectively, of that of TCPN.
采用原位灌注大鼠肝脏制备方法研究了新型抗胆碱能药物盐酸三环哌酯(TCPN)的代谢情况。通过高效液相色谱法分离出两种代谢产物。代谢产物I被鉴定为N-去甲基化产物,而代谢产物II被证明是芳基羟基化产物。代谢产物I和代谢产物II也从经口给予TCPN的大鼠尿液中分离得到。该结果表明,来自灌注大鼠肝脏的这两种代谢产物正是体内产生的最终代谢产物。大鼠肝脏微粒体中的代谢产物也被鉴定为上述代谢产物。这些结果表明,TCPN的生物转化反应主要由大鼠肝脏微粒体中的酶催化。受体活性实验结果表明,代谢产物I和代谢产物II对毒蕈碱型乙酰胆碱受体(mAChR)的作用效价分别仅为TCPN的1/20和1/50。